PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report.

Abstract The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodies against F. hepatica in the serum samples of HCC patients.
PMID
Related Publications

Immunodiagnosis of human fascioliasis with Fasciola hepatica cysteine proteinases.

Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis.

Detection of antibodies against Fasciola hepatica in cirrhotic patients from Peru.

Anti-Fas2 IgM antibodies in Fasciola hepatica infected patients with positive IgG serology.

Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans.

Authors

Mayor MeshTerms
Keywords
Journal Title revista da sociedade brasileira de medicina tropical
Publication Year Start




PMID- 29768560
OWN - NLM
STAT- MEDLINE
DCOM- 20180524
LR  - 20180524
IS  - 1678-9849 (Electronic)
IS  - 0037-8682 (Linking)
VI  - 51
IP  - 2
DP  - 2018 Mar-Apr
TI  - Negative serology of Fasciola hepatica infection in patients with liver cancer in
      Peru: a preliminary report.
PG  - 231-233
LID - S0037-86822018000200231 [pii]
LID - 10.1590/0037-8682-0180-2017 [doi]
AB  - INTRODUCTION: The etiology of several hepatocellular carcinoma (HCC) cases
      remains largely unknown. Although Fasciola hepatica has been associated with
      liver fibrosis in Latin America, it has not yet been associated with HCC. This
      study aimed to determine the existence of specific IgG antibodies against F.
      hepatica in the serum samples of HCC patients. METHODS: In total, 13 serum
      samples from 13 HCC patients were screened using Fas2-ELISA. RESULTS: Fas2-ELISA 
      demonstrated negative results in all HCC patients included in this study.
      CONCLUSIONS: The pre-existence of F. hepatica infection in HCC patients needs to 
      be further investigated in epidemiological and experimental studies.
FAU - Machicado, Claudia
AU  - Machicado C
AD  - Laboratorios de Investigacion y Desarrollo, Facultad de Ciencias y Filosofia,
      Universidad Peruana Cayetano Heredia. Lima, Peru.
AD  - Institute for Biocomputation and Physics of Complex Systems, University of
      Zaragoza, Zaragoza, Spain.
FAU - Bertani, Stephane
AU  - Bertani S
AD  - Universite de Toulouse, IRD, UPS, UMR 152 PHARMA-DEV, Toulouse, France.
FAU - Herrera-Velit, Patricia
AU  - Herrera-Velit P
AD  - Laboratorios de Investigacion y Desarrollo, Facultad de Ciencias y Filosofia,
      Universidad Peruana Cayetano Heredia. Lima, Peru.
FAU - Espinoza, Jose
AU  - Espinoza J
AD  - Laboratorios de Investigacion y Desarrollo, Facultad de Ciencias y Filosofia,
      Universidad Peruana Cayetano Heredia. Lima, Peru.
FAU - Ruiz, Eloy
AU  - Ruiz E
AD  - Departamento de Cirugia en Abdomen, Instituto Nacional de Enfermedades
      Neoplasicas, Lima, Peru.
FAU - Marcos, Luis
AU  - Marcos L
AD  - Department of Internal Medicine, Division of Infectious Diseases, Department of
      Microbiology and Genetics, Global Health Institute, Stony Brook University, Stony
      Brook. New York.USA.
LA  - eng
PT  - Journal Article
PL  - Brazil
TA  - Rev Soc Bras Med Trop
JT  - Revista da Sociedade Brasileira de Medicina Tropical
JID - 7507456
RN  - 0 (Antibodies, Helminth)
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Animals
MH  - Antibodies, Helminth/*blood
MH  - Carcinoma, Hepatocellular/blood/*parasitology
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Fasciola hepatica/*immunology
MH  - Fascioliasis/*complications/diagnosis
MH  - Female
MH  - Humans
MH  - Immunoglobulin G/*blood
MH  - Liver Neoplasms/blood/*parasitology
MH  - Male
MH  - Middle Aged
MH  - Peru
MH  - Risk Factors
MH  - Young Adult
EDAT- 2018/05/17 06:00
MHDA- 2018/05/25 06:00
CRDT- 2018/05/17 06:00
PHST- 2017/05/02 00:00 [received]
PHST- 2017/09/29 00:00 [accepted]
PHST- 2018/05/17 06:00 [entrez]
PHST- 2018/05/17 06:00 [pubmed]
PHST- 2018/05/25 06:00 [medline]
AID - S0037-86822018000200231 [pii]
AID - 10.1590/0037-8682-0180-2017 [doi]
PST - ppublish
SO  - Rev Soc Bras Med Trop. 2018 Mar-Apr;51(2):231-233. doi:
      10.1590/0037-8682-0180-2017.